Direct-to-consumer/patient advertising of genetic testing: a position statement of the American College of Clinical Pharmacology.

This position paper’s focus—advertising of genetic
testing services directly to the consumer/patient—has been thrust into the headlines by action taken by state health departments in California and New York against certain private testing companies. The topic is compelling to clinical pharmacologists because the response of consumers to such advertising can have both immediate and long-term effects on public health and the future adoption of pharmacogenetic/genomic testing.